drugset / Trial / NCT03242824

The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma

NCT03242824

Phase 2 Completed 21 enrolled Mayo Clinic
NaSingle-groupOpen-labelTreatment

Summary

This proposal is for a pilot study comparing volumes of 18F-DOPA-PET avidity with contrast enhancement and T2 FLAIR on MRI. Investigators then plan to compare patterns of failure with target volumes, pre-treatment MRI changes and pre-treatment 18F-DOPA-PET.

Timeline

Start
2017-09-29
Primary completion
2020-06-16
Completion
2021-06-16

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DOPA Diagnostic / imaging agent

Indications